European Commission approves rituximab biosimilarFebruary 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Immunotherapy receives fast track designationFebruary 22, 2017Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Styrene exposure linked to myeloid leukemia, HLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLHodgkin LymphomaCMLAggressive Lymphomas
G-CSF could prevent infertility in cancer patientsFebruary 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAggressive Lymphomas
How EBV causes lymphoma, other cancersFebruary 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Team creates online database of cancer mutationsFebruary 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
Investigators report new risk loci for CLLFebruary 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Obinutuzumab approved to treat FL in CanadaFebruary 8, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Study provides new insight into B-cell metabolismJanuary 29, 2017Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Study quantifies 5-year survival rates for blood cancersJanuary 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Improving the efficacy of obinutuzumabJanuary 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Overcoming glucocorticoid resistance in lymphomaJanuary 23, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves ibrutinib to treat rel/ref MZLJanuary 20, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Prolonged work-related stress linked to NHL, other cancers in menJanuary 19, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Venetoclax approved to treat CLL in AustraliaJanuary 12, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas